IN SILICO STUDY OF VANILLIN SCHIFF BASES AS PROTO ONCOGENE TYROSINE KINASE INHIBITORS OF CHRONIC MYELOID LEUKEMIA. FMHR. 2025;3(10):570-577. Accessed November 10, 2026. https://fmhr.net/index.php/fmhr/article/view/1765